Taysha Gene Therapies Investor Webcast to Discuss New Clinical Data from REVEAL Phase 1/2 Adolescent and Adult Trial and REVEAL Phase 1/2 Pediatric Trial Evaluating TSHA-102 in Rett Syndrome
| DATE: | June 18, 2024 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Join Taysha Gene Therapies on Tuesday, June 18, 2024, to discuss new clinical data from the REVEAL Phase 1/2 adolescent and adult trial and the REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in Rett syndrome, as well as a program update on TSHA-102.
A live question and answer session will follow the formal presentation.